Open AccessIs MRI helpful in evaluating the response of cervical cancer to neoadjuvant chemotherapy?
Author(s) -
Vives A.,
CasteloBranco C.,
Iglesias X.,
Tomás X.,
Palombo H.,
Pahisa J.,
Lejárcegui J. A.,
Salvador A.,
PuigTintoré Li
Publication year - 1995
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.3109/00016349509024411
Subject(s) - parametrial , medicine , laparotomy , chemotherapy , magnetic resonance imaging , cervix , radiology , cervical cancer , neoadjuvant therapy , cervical carcinoma , cancer , surgery , breast cancer
Background . To assess the potential role of magnetic resonance imaging (MRI) in evaluating the response of cervical tumor to neoadjuvant chemotherapy. Methods . We studied 14 patients with locally advanced carcinoma of the cervix. MRI was performed before and after each cycle. All patients underwent laparotomy four weeks after the last cycle. MR images after chemotherapy were compared with surgical‐pathologic findings. Results . Related to parametrial state after chemotherapy, surgical examination correlated with MRI in nine patients (nine true negative). In three cases parametrial invasion was overestimated (three false‐positive) and in two it was underestimated, so that tumor resection was not possible once laparotomy was performed (two false‐negative). MRI estimation of tumor size was confirmed at pathologic examination in only eight patients, whilst it was overestimated in the other four ones. Conclusions . These initial results suggest that MRI could not be as precise for cervix cancer staging and evaluation of response to chemotherapy as has recently been postulated. This is especially important since a false negative result may induce the surgeon to perform laparotomy in error in cases of unresectable tumors.